<DOC>
	<DOCNO>NCT01346579</DOCNO>
	<brief_summary>This research trial study phosphatidylinositol-4,5-bisphosphate 3-kinase , catalytic subunit alpha ( PIK3CA ) mutation analysis tissue sample old patient stage I breast cancer . Studying sample tissue patient stage I breast cancer laboratory may help doctor learn change occur deoxyribonucleic acid ( DNA ) identify biomarkers related cancer .</brief_summary>
	<brief_title>Biomarkers Tissue Samples From Older Women With Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : To assess relapse free-survival difference patient PIK3CA mutate wild-type ( WT ) tumor therefore validate PIK3CA mutation status important biomarker woman 70 year old diagnose breast cancer . OUTLINE : Previously collect tissue sample analyze via mutation analysis PIK3CA .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Participants stage I breast cancer ( T1N0M0 ) estrogenreceptor status positive unknown Patients underwent lumpectomy negative margin clinically nodenegative</criteria>
	<gender>Female</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>estrogen receptor-positive breast cancer</keyword>
</DOC>